Jain Global »

C4 Therapeutics shares owned by Jain Global

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Jain Global

Quarter filed Position value Share count Share price at filing
2025-12-31 $24k 13k 1.91
2025-06-30 $195k 136k 1.43
2025-03-31 $39k 24k 1.60

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)
Boeing Company (BA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Jain Global

Top funds holding C4 Therapeutics

Point72 Asset Management
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Daniel D. Thurber
Soleus Capital Management
Silverarc Capital Management
BlackRock
Susquehanna International
Renaissance Technologies
Two Sigma Investments
OrbiMed Advisors
Millennium Management
Goldman Sachs Group

View all funds holding C4 Therapeutics